Cited by 128Microbial Natural Products and BiosynthesisAntibiotic Resistance in BacteriaSynthesis of β-Lactam Compounds

Clavulanic acid: a review

Saudagar, Parag S., Survase, Shrikant A., Singhal, Rekha S.·2008·Biotechnology Advances

Abstract

Natural antibiotics are almost universal secondary metabolites, not essential for the growth of the producing organisms generally produced at low growth rates or after growth has ceased. Clavulanic acid (CA), a naturally occurring powerful inhibitor of bacterial beta-lactamases is a major beta-lactam antibiotic produced by organism Streptomyces clavuligerus and is active against a wide spectrum of Gram-positive and Gram-negative bacteria. The review discusses the biosynthetic pathway, fermentative production, downstream processing and applications of CA.

Integrity signals

Registry

Crossref · 10.1016/j.biotechadv.2008.03.002

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clavulanic acid prevents degradation of the β-lactam ring, thereby preventing resistance of pathogens to β-lactam antibiotics.

    “Clavulanic acid prevents drug resistance by pathogens against these β-lactam antibiotics by preventing the degradation of the β-lactam ring, thus ensuring eradication of these harmful microorganisms from the host.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Saudagar, P. S., Survase, S. A., & Singhal, R. S.
Affiliations
Institute of Chemical Technology (IN)
Corresponding author
Singhal, Rekha S.
Venue
Biotechnology Advances
Publisher
Elsevier BV
Published
2008-07
Volume
26
Issue
4
Pages
335-351
ISSN
0734-9750 (ISSN-L)
OpenAlex
W2011886013
Cited by
128
References
2
Citations by year
2026: 8 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 14 · 2021: 10 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 4 · 2014: 8 · 2013: 8 · 2012: 5
FWCI
0.61
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Advances (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords
clavulanic acid, beta-lactamase inhibitors, Streptomyces clavuligerus, secondary metabolites, biosynthetic pathway, fermentation production, downstream processing, antibiotic applications, Gram-positive and Gram-negative bacteria
MeSH terms
Animals, Communicable Diseases, Fermentation, Humans, Clavulanic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review